Quarterly report pursuant to Section 13 or 15(d)

Summary of Stock Option Activity (Details)

v3.24.2.u1
Summary of Stock Option Activity (Details) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]    
Number of Shares, Outstanding, Beginning balance 244,733  
Weighted Average Exercise Price, Outstanding, Beginning balance $ 20.17  
Weighted Average Remaining Contractual Term (In Years), Outstanding 8 years 3 months 14 days 7 years 11 months 15 days
Aggregate Intrinsic Value, Outstanding, Beginning balance [1]  
Number of Shares, Granted  
Weighted Average Exercise Price, Granted  
Number of Shares, Expired (17,146)  
Weighted Average Exercise Price, Expired $ 28.44  
Number of Shares, Forfeited (4,667)  
Weighted Average Exercise Price, Forfeited $ 11.52  
Number of Shares, Outstanding, Ending balance 222,920 244,733
Weighted Average Exercise Price, Outstanding, Ending balance $ 19.72 $ 20.17
Aggregate Intrinsic Value, Outstanding, Ending balance [1]
Number of Shares, Exercisable, Ending balance 186,370  
Weighted Average Exercise Price, Exercisable, Ending balance $ 22.55  
Weighted Average Remaining Contractual Term (In Years), Exercisable 8 years 25 days  
Aggregate Intrinsic Value, Exercisable, Ending balance [1]  
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our common stock as of December 31, 2023 and June 30, 2024; respectively.